NYSE · SIC 2844
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
Colgate-Palmolive Company manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. The Pet Nutrition segment offers pet nutrition products for everyday nutritional needs under Hill's Science Diet brand.
Roles derived from SEC Form 4 filings.
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
| Line item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | $16.5B | $17.4B | $18.0B | $19.5B | $20.1B | $20.4B |
| Gross profit | $10.0B | $10.4B | $10.2B | $11.3B | $12.2B | $12.3B |
| Operating income | $3.9B | $3.3B | $2.9B | $4.0B | $4.3B | $3.3B |
| Net income | $2.7B | $2.2B | $1.8B | $2.3B | $2.9B | $2.1B |
| Diluted EPS | $3.14 | $2.55 | $2.13 | $2.77 | $3.51 | $2.63 |
| Operating cash flow | $3.7B | $3.3B | $2.6B | $3.7B | $4.1B | $4.2B |
| Free cash flow | $3.3B | $2.8B | $1.9B | — | — | — |
| Gross margin | 60.8% | 59.6% | 57.0% | 58.2% | 60.5% | 60.1% |
| Operating margin | 23.6% | 19.1% | 16.1% | 20.5% | 21.2% | 16.2% |
| Net margin | 16.4% | 12.4% | 9.9% | 11.8% | 14.4% | 10.5% |
| Line item | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $5.1B | $5.0B | $4.9B | $4.9B | $5.1B | $5.1B | $5.2B | $5.3B |
| Gross profit | $3.1B | $3.1B | $3.0B | $3.0B | $3.1B | $3.0B | $3.1B | $3.2B |
| Operating income | $1.1B | $1.1B | $1.1B | $1.1B | $1.1B | $1.1B | $91.0M | $964.0M |
| Net income | $731.0M | $737.0M | $738.0M | $690.0M | $743.0M | $735.0M | -$36.0M | $646.0M |
| Diluted EPS | $0.89 | $0.90 | $0.89 | $0.85 | $0.91 | $0.91 | -$0.04 | $0.80 |
| Operating cash flow | $990.0M | $1.2B | $1.3B | $600.0M | $884.0M | $1.3B | $1.5B | $747.0M |
| Free cash flow | — | — | — | — | — | — | — | — |
| Gross margin | 60.6% | 61.1% | 60.3% | 60.8% | 60.1% | 59.4% | 60.2% | 60.6% |
| Operating margin | 21.6% | 21.2% | 21.5% | 21.9% | 21.1% | 20.6% | 1.7% | 18.1% |
| Net margin | 14.5% | 14.6% | 14.9% | 14.1% | 14.5% | 14.3% | -0.7% | 12.1% |
Consensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
| Date | Insider | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-07-01 | NORRINGTON LORRIE M | Award | 293 | $89.45 | $26,208.85 | filing |
| 2026-07-01 | BILBREY JOHN P | Award | 265 | $89.45 | $23,704.25 | filing |
| 2026-07-01 | Newman Brian | Award | 209 | $89.45 | $18,695.05 | filing |
| 2026-06-16 | GRANT SHANE· COO, Americas | Tax withholding | 23,347 | $90.66 | $2.1M | filing |
| 2026-05-15 | Malcolm Gregory· EVP and Controller | Sale | 2,300 | $88.44 | $203,412.00 | filing |
| 2026-05-11 | Edwards Lisa | Award | 2,075 | $0.00 | $0.00 | filing |
| 2026-05-11 | CAHILL JOHN T | Award | 2,075 | $0.00 | $0.00 | filing |
| 2026-05-11 | BOERNER CHRISTOPHER S. | Award | 1,383 | $0.00 | $0.00 | filing |
| 2026-05-11 | BILBREY JOHN P | Award | 2,075 | $0.00 | $0.00 | filing |
| 2026-05-11 | NORRINGTON LORRIE M | Award | 2,075 | $0.00 | $0.00 | filing |
| 2026-05-11 | Newman Brian | Award | 2,075 | $0.00 | $0.00 | filing |
| 2026-05-11 | Nelson Kimberly A | Award | 2,075 | $0.00 | $0.00 | filing |
| 2026-05-11 | HUNDMEJEAN MARTINA | Award | 2,075 | $0.00 | $0.00 | filing |
| 2026-05-11 | HARRIS C MARTIN | Award | 1,556 | $0.00 | $0.00 | filing |
| 2026-05-07 | Massey Sally· Chief People Officer | Sale | 8,599 | $87.41 | $751,632.57 | filing |
| 2026-04-01 | NORRINGTON LORRIE M | Award | 294 | $89.05 | $26,180.70 | filing |
| 2026-04-01 | BILBREY JOHN P | Award | 266 | $89.05 | $23,687.30 | filing |
| 2026-04-01 | Newman Brian | Award | 210 | $89.05 | $18,700.50 | filing |
| 2026-02-23 | Wallace Noel R.· Chairman, President & CEO | Tax withholding | 68,252 | $97.10 | $6.6M | filing |
| 2026-02-23 | SUTULA STANLEY J III· Chief Financial Officer | Tax withholding | 19,746 | $97.10 | $1.9M | filing |
| 2026-02-23 | Tsourapas Panagiotis· COO, Eur., APac, Afr Eur, Skin | Tax withholding | 13,081 | $97.10 | $1.3M | filing |
| 2026-02-23 | Daniels Jennifer· CLO and Secretary | Tax withholding | 12,351 | $97.10 | $1.2M | filing |
| 2026-02-23 | Massey Sally· Chief Human Resources Officer | Tax withholding | 8,206 | $97.10 | $796,802.60 | filing |
| 2026-02-23 | Hazlin John· Chief Growth Officer | Tax withholding | 6,117 | $97.10 | $593,960.70 | filing |
| 2026-02-23 | Malcolm Gregory· EVP and Controller | Tax withholding | 2,260 | $97.10 | $219,446.00 | filing |
Showing the latest 25 transactions — full history in the linked SEC filings.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.